Schrödinger, Inc. Logo

Schrödinger, Inc.

SDGR

(1.2)
Stock Price

19,44 USD

-29.47% ROA

-35.77% ROE

-6.18x PER

Market Cap.

1.246.640.576,00 USD

26.15% DER

0% Yield

-91.84% NPM

Schrödinger, Inc. Stock Analysis

Schrödinger, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Schrödinger, Inc. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (23%), which means it has a small amount of debt compared to the ownership it holds

2 ROE

ROE in an average range (7.99%) suggests satisfactory profitability and decent utilization of shareholders' equity.

3 ROA

The stock's ROA (5.6%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

4 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is undervalued (257), making it an appealing investment prospect with its intrinsic value surpassing the current market price.

5 PBV

The stock's elevated P/BV ratio (3.94x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

6 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

7 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

8 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

10 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

11 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

Schrödinger, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Schrödinger, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Sell
4 Stoch RSI Sell

Schrödinger, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Schrödinger, Inc. Revenue
Year Revenue Growth
2017 55.693.000
2018 66.639.000 16.43%
2019 85.543.000 22.1%
2020 108.095.000 20.86%
2021 137.931.000 21.63%
2022 180.955.000 23.78%
2023 170.276.000 -6.27%
2023 216.666.000 21.41%
2024 189.336.000 -14.43%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Schrödinger, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2017 27.669.000
2018 34.523.000 19.85%
2019 39.404.000 12.39%
2020 64.695.000 39.09%
2021 90.904.000 28.83%
2022 126.372.000 28.07%
2023 187.332.000 32.54%
2023 181.766.000 -3.06%
2024 203.340.000 10.61%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Schrödinger, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2017 14.436.000
2018 18.552.000 22.19%
2019 27.040.000 31.39%
2020 41.898.000 35.46%
2021 64.009.000 34.54%
2022 90.825.000 29.52%
2023 95.560.000 4.96%
2023 99.148.000 3.62%
2024 94.144.000 -5.32%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Schrödinger, Inc. EBITDA
Year EBITDA Growth
2017 -15.695.000
2018 -24.263.000 35.31%
2019 -44.997.000 46.08%
2020 -85.521.000 47.38%
2021 -119.955.000 28.71%
2022 -144.779.000 17.15%
2023 -161.592.000 10.4%
2023 -171.896.000 5.99%
2024 -205.312.000 16.28%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Schrödinger, Inc. Gross Profit
Year Gross Profit Growth
2017 39.800.000
2018 42.937.000 7.31%
2019 49.093.000 12.54%
2020 63.472.000 22.65%
2021 65.620.000 3.27%
2022 101.022.000 35.04%
2023 94.556.000 -6.84%
2023 140.105.000 32.51%
2024 125.340.000 -11.78%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Schrödinger, Inc. Net Profit
Year Net Profit Growth
2017 -17.392.000
2018 -28.425.000 38.81%
2019 -25.681.000 -10.68%
2020 -26.637.000 3.59%
2021 -101.219.000 73.68%
2022 -149.189.000 32.15%
2023 -248.096.000 39.87%
2023 40.720.000 709.27%
2024 -216.188.000 118.84%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Schrödinger, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2017 0
2018 -1 0%
2019 0 0%
2020 0 0%
2021 -1 100%
2022 -2 50%
2023 -3 33.33%
2023 1 0%
2024 -3 100%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Schrödinger, Inc. Free Cashflow
Year Free Cashflow Growth
2017 -19.007.000
2018 -28.970.000 34.39%
2019 -27.895.000 -3.85%
2020 14.219.000 296.18%
2021 -77.836.000 118.27%
2022 -127.697.000 39.05%
2023 -54.858.000 -132.78%
2023 -2.923.000 -1776.77%
2024 -54.723.999 94.66%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Schrödinger, Inc. Operating Cashflow
Year Operating Cashflow Growth
2017 -15.307.000
2018 -23.711.000 35.44%
2019 -26.059.000 9.01%
2020 16.757.000 255.51%
2021 -70.669.000 123.71%
2022 -119.683.000 40.95%
2023 -49.941.000 -139.65%
2023 10.480.000 576.54%
2024 -53.723.000 119.51%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Schrödinger, Inc. Capital Expenditure
Year Capital Expenditure Growth
2017 3.700.000
2018 5.259.000 29.64%
2019 1.836.000 -186.44%
2020 2.538.000 27.66%
2021 7.167.000 64.59%
2022 8.014.000 10.57%
2023 4.917.000 -62.99%
2023 13.403.000 63.31%
2024 1.000.999 -1238.96%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Schrödinger, Inc. Equity
Year Equity Growth
2017 -45.362.000
2018 -71.560.000 36.61%
2019 -93.323.000 23.32%
2020 624.019.000 114.96%
2021 557.085.000 -12.02%
2022 447.905.000 -24.38%
2023 548.558.000 18.35%
2023 563.581.000 2.67%
2024 473.980.000 -18.9%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Schrödinger, Inc. Assets
Year Assets Growth
2017 58.022.000
2018 120.730.000 51.94%
2019 155.270.000 22.25%
2020 746.263.000 79.19%
2021 756.487.000 1.35%
2022 688.587.000 -9.86%
2023 802.955.000 14.24%
2023 794.148.000 -1.11%
2024 688.371.000 -15.37%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Schrödinger, Inc. Liabilities
Year Liabilities Growth
2017 103.384.000
2018 192.290.000 46.24%
2019 248.593.000 22.65%
2020 122.244.000 -103.36%
2021 199.402.000 38.69%
2022 240.682.000 17.15%
2023 254.397.000 5.39%
2023 230.567.000 -10.34%
2024 214.391.000 -7.55%

Schrödinger, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
2.76
Net Income per Share
-2.77
Price to Earning Ratio
-6.18x
Price To Sales Ratio
6.21x
POCF Ratio
-6.91
PFCF Ratio
-6.47
Price to Book Ratio
2.63
EV to Sales
6.27
EV Over EBITDA
-6.48
EV to Operating CashFlow
-6.99
EV to FreeCashFlow
-6.53
Earnings Yield
-0.16
FreeCashFlow Yield
-0.15
Market Cap
1,25 Bil.
Enterprise Value
1,26 Bil.
Graham Number
20.16
Graham NetNet
2.84

Income Statement Metrics

Net Income per Share
-2.77
Income Quality
0.89
ROE
-0.38
Return On Assets
-0.27
Return On Capital Employed
-0.39
Net Income per EBT
1
EBT Per Ebit
0.82
Ebit per Revenue
-1.13
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
0.49
Research & Developement to Revenue
1
Stock Based Compensation to Revenue
0.25
Gross Profit Margin
0.65
Operating Profit Margin
-1.13
Pretax Profit Margin
-0.92
Net Profit Margin
-0.92

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-2.48
Free CashFlow per Share
-2.65
Capex to Operating CashFlow
-0.07
Capex to Revenue
0.06
Capex to Depreciation
2.29
Return on Invested Capital
-0.34
Return on Tangible Assets
-0.29
Days Sales Outstanding
94.91
Days Payables Outstanding
42.8
Days of Inventory on Hand
0
Receivables Turnover
3.85
Payables Turnover
8.53
Inventory Turnover
69213000
Capex per Share
0.17

Balance Sheet

Cash per Share
5,25
Book Value per Share
6,52
Tangible Book Value per Share
6.45
Shareholders Equity per Share
6.52
Interest Debt per Share
1.7
Debt to Equity
0.26
Debt to Assets
0.18
Net Debt to EBITDA
-0.06
Current Ratio
4.5
Tangible Asset Value
0,47 Bil.
Net Current Asset Value
0,23 Bil.
Invested Capital
496459000
Working Capital
0,35 Bil.
Intangibles to Total Assets
0.01
Average Receivables
0,05 Bil.
Average Payables
0,01 Bil.
Average Inventory
1
Debt to Market Cap
0.1

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Schrödinger, Inc. Dividends
Year Dividends Growth

Schrödinger, Inc. Profile

About Schrödinger, Inc.

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

CEO
Dr. Ramy Farid Ph.D.
Employee
900
Address
1540 Broadway
New York, 10036

Schrödinger, Inc. Executives & BODs

Schrödinger, Inc. Executives & BODs
# Name Age
1 Dr. Richard A. Friesner Ph.D.
Co-Founder, Scientific Advisory Chairman and Director
70
2 Ms. Jaren Irene Madden
Senior Vice President of Investor Relations & Corporate Affairs
70
3 Dr. Margaret Han Dugan M.D.
Chief Medical Officer
70
4 Mr. Shane Brauner
Executive Vice President & Chief Information Officer
70
5 Prof. William Goddard III
Co-Founder & Scientific Advisor
70
6 Dr. Ramy Farid Ph.D.
Chief Executive Officer, President & Director
70
7 Dr. Karen Akinsanya Ph.D.
President of Research & Development Therapeutics
70
8 Dr. Robert Lorne Abel Ph.D.
Executive Vice President, Chief Scientific Officer of Platform and Head of Modeling R&D
70
9 Mr. Kenneth Patrick Lorton
Executive Vice President, Chief Technology Officer & Chief Operating Officer of Software
70
10 Dr. Geoffrey Craig Porges MBBS
Executive Vice President & Chief Financial Officer
70

Schrödinger, Inc. Competitors

Veeva Systems Inc. Logo
Veeva Systems Inc.

VEEV

(2.5)
Doximity, Inc. Logo
Doximity, Inc.

DOCS

(2.0)
10x Genomics, Inc. Logo
10x Genomics, Inc.

TXG

(1.0)
Progyny, Inc. Logo
Progyny, Inc.

PGNY

(2.2)
Certara, Inc. Logo
Certara, Inc.

CERT

(1.8)
HealthEquity, Inc. Logo
HealthEquity, Inc.

HQY

(2.0)
R1 RCM Inc. Logo
R1 RCM Inc.

RCM

(1.2)
Accolade, Inc. Logo
Accolade, Inc.

ACCD

(1.2)